Business Assets for Sale

Our game is a successful product sold in several countries and in several languages. This company as a licensed seller, announces the sale of the license right for the board game, the duration of which is 5 or 10 years. The license right sale includes the following: • 5 or 10-year right, which gives buyer the exclusive right to sell the companion. The game within the country is included in the contract. This applies to both traders and private individuals. • Complete translation and proofreading of the game to the agreed language mutation. • Graphic design of the game, complete printing graphics of the game, which you can send as finished material to the selected printing house. • Tantra massage video narration for the selected language mutation. • Preparation of a presentation in the selected language for your future partners. • Tantra massage video link, which the customer can download, since the video is part of the game. • Supplier contact information for purchasing game accessories. (If required) By purchasing the license right, we claim the following: • The quality of the printing production must match the quality of the board. We will need a sample of the game (translated copy) and the props. • The quality of the game props must match the quality of the props we manufacture. • The website used to sell the game must be similar to the original website. • Buyer can only sell the board game in the country indicated in the contract.

Start-up owns a formula of medicine that prevents and/or treats coronavirus symptoms. - It is an alternative medicine due to its all-natural and herbal ingredients. - Potential market will be the segment of the world population who decline vaccines and another potential market can be the vaccinated who need the added support. - List of ingredients will be disclosed upon sale of the medicine formula. - The medicine has been developed by a university and this start-up owns the formula. - Currently, the only asset available for sale is the all-natural Covid-19 medicine formula. - Patent approval is in pending status.

This sale includes only the sale of machinery and raw materials. We specialize in producing plastic granules (HD-PE, LD-PE, PP, PET) and wood sawdust briquettes. The productivity of PET production is processing 5 tons of raw materials in 1 day. The productivity of PP. HD PE, LD PE is 4.5 tons per day. We currently have pressed raw materials in stock which will also be a part of this sale. Any plastic manufacturer can acquire these assets and start or expand their operations. There are no loans or debts associated with the assets on sale. The business is not operational right now.

This is an asset sale only. - Includes machinery for the production of paper carry bags and inventory. - The bags, both printed and unprinted, are primarily supplied to retail food outlets. - Paper carry bags are widely used as eco-friendly packaging solutions, especially by retail food outlets for takeaway and grocery items. - The machinery includes three paper bag machines, a six-color flexographic printing machine, a slitting machine, and taping lines. - The machinery has a capacity of 3 million units per month and was regularly used to produce 2 million units each month. - The machinery is worth EUR 1.5 million and the inventory is worth EUR 500K.

Our company is offering its unsecured consumer credit card program IP assets, including the: - Proprietary rewards platform. - Complete technology infrastructure and customer acquisition playbook. The card currently offers 3X rewards on automotive expenses (auto loans, insurance, gas, maintenance), but the rewards structure and underwriting criteria are fully customizable by the buyer. This is an IP-only asset sale of an unsecured consumer credit card program, covering the proprietary rewards platform, underlying technology, and customer acquisition playbook. No physical assets, property, leases, or operating business are included. The buyer acquires only the IP of the proprietary rewards platform, complete technology infrastructure and customer acquisition playbook. This IP is valued at about USD 16 million but is being sold for USD 3 million.